Marker Therapeutics, Inc.

News

TapImmune Provides Operational Update including Human Data Supporting Use of TAP Based Cancer Vaccine Company Establishes Laboratory Facilities in Vancouver Canada

…ANCOUVER, Canada, 31 July, 2007 – TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, opens new laboratory facilities and provides this update to shareholders.

The opening of the new laboratory facility in Vancouver facilitates the transfer of its technology from The University of British Columbia and signifies the start of the Pre-Clinical process to commercialize its core TAP technologies.

Read More

TapImmune Inc. Announces Availability of New Investor Information

…VANCOUVER, British Columbia, July 17, 2007 (PRIME NEWSWIRE) — TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has launched a new corporate website with links to media features on its technologies.

“I am pleased to have this resource available to our shareholders and other interested parties as it provides a comprehensive look at the company and our technology,” said TapImmune Inc.

Read More

TapImmune Inc. Announces Acquisition of Core TAP Technologies and Intellectual Property from The University of British Columbia

…New Name to Reflect a New Direction and Independent Operation

VANCOUVER, BC – TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has fulfilled its financial obligation to The University of British Columbia for the proposed acquisition of its key Transporter Associated with Antigen Processing (TAP) technology platform and patents.

Read More

TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma

Qian-Jin Zhang, Robyn P. Seipp, Susan S. Chen, Timothy Z. Vitalis, Xiao-Lin Li1, Kyung-Bok Choi, Andrew Jeffries, and Wilfred A. Jefferies

http://www3.interscience.wiley.com/cgi-bin/abstract/114110086/ABSTRACT

Read More

Using the TAP Component of the Antigen-Processing Machinery as a Molecular Adjuvant

Timothy Z. Vitalis, Qian-Jin Zhang, Judie Alimonti, Susan S. Chen, Genc Basha, Alex Moise, Jacqueline Tiong, Mei Mei Tian, Kyung Bok Choi, Douglas Waterfield, Andy Jeffries, Wilfred A. Jefferies
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1323471/?report=abstract

Read More

Restoration of the Expression of Transporters Associated with Antigen Processing in Lung Carcinoma Increases Tumor-Specific Immune Responses and Survival

Yuanmei Lou, Timothy Z. Vitalis, Genc Basha, Bing Cai, Susan S. Chen, Kyung Bok Choi, Andrew P. Jeffries, W. Mark Elliott, Derek Atkins, Barbara Seliger, and Wilfred A. Jefferies
http://cancerres.aacrjournals.org/content/65/17/7926.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Vitalis%252C+T&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Read More

Identification of Mechanisms Underlying Transporter Associated with Antigen Processing Deficiency in Metastatic Murine Carcinomas

A. Francesca Setiadi, Muriel D. David, Susan S. Chen, John Hiscott and Wilfred A. Jefferies
http://cancerres.aacrjournals.org/content/65/16/7485.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Jefferies%252C+W&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Read More

CTL-Dependent and -Independent Antitumor Immunity Is Determined by the Tumor Not the Vaccine

Jaina Leitch, Katie Fraser, Cecilia Lane, Kelley Putzu, Gosse J. Adema, Qian-Jin Zhang, Wilfred A. Jefferies, Jonathan L. Bramson and Yonghong Wan
http://www.jimmunol.org/content/172/9/5200.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&author1=Jefferies%252C+W&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&fdate=1/1/2004&tdate=12/31/2004&resourcetype=HWCIT

Read More

TAP expression provides a general method for improving the recognition of malignant cells in vivo

Judy Alimonti, Qian-Jin Zhang, Reinhard Gabathuler, Gregor Reid, Susan S. Chen, and Wilfred A. Jefferies
http://www.nature.com/nbt/journal/v18/n5/abs/nbt0500_515.html

Read More